Stereochemical Studies on Medicinal Agents. 10.1 The Role of Chirality in α-Adrenergic Receptor Blockage by (+)- and (-)-Phenoxybenzamine Hydrochloride3

P. S. Portoghese, T. N. Riley, J. W. Miller

Research output: Contribution to journalArticlepeer-review

18 Scopus citations

Abstract

The synthesis and absolute configurational assignment of (+)- and (-)-phenoxybenzamine. HCl (1) were accomplished by utilization of (R)- and (S)-alanine as starting materials, (S)-(+)-1 was 14.5 times more potent than (S)-(-)-1 while the desmethyl analog 2 possessed intermediate αadrenergic blocking activity. Evidence is presented which suggests that the potency difference between enantiomers is due to an affinity difference for the receptor rather than to a difference in intrinsic alkylating capacity. The differences in affinity between (R)-(+ )-1, (S)-( - )-1, and 2 are postulated to be related to the abilities of the aziridinium species derived from these compounds to achieve a negative synclinal conformation and to the binding energy afforded by a properly oriented methyl group.

Original languageEnglish (US)
Pages (from-to)561-564
Number of pages4
JournalJournal of medicinal chemistry
Volume14
Issue number7
DOIs
StatePublished - Jul 1 1971

Fingerprint

Dive into the research topics of 'Stereochemical Studies on Medicinal Agents. 10.<sup>1</sup> The Role of Chirality in α-Adrenergic Receptor Blockage by (+)- and (-)-Phenoxybenzamine Hydrochloride<sup>3</sup>'. Together they form a unique fingerprint.

Cite this